These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8729161

  • 41. Apolipoprotein A-IV levels and phenotype distribution in NIDDM.
    Vergès BL, Vaillant G, Goux A, Lagrost L, Brun JM, Gambert P.
    Diabetes Care; 1994 Aug; 17(8):810-7. PubMed ID: 7956623
    [Abstract] [Full Text] [Related]

  • 42. Atorvastatin 10 mg plus ezetimibe 10mg compared with atorvastatin 20 mg: impact on the lipid profile in Japanese patients with abnormal glucose tolerance and coronary artery disease.
    Uemura Y, Watarai M, Ishii H, Koyasu M, Takemoto K, Yoshikawa D, Shibata R, Matsubara T, Murohara T.
    J Cardiol; 2012 Jan; 59(1):50-6. PubMed ID: 22100058
    [Abstract] [Full Text] [Related]

  • 43. Age-related alteration of pancreatic beta-cell function. Increased proinsulin and proinsulin-to-insulin molar ratio in elderly, but not in obese, subjects without glucose intolerance.
    Shimizu M, Kawazu S, Tomono S, Ohno T, Utsugi T, Kato N, Ishi C, Ito Y, Murata K.
    Diabetes Care; 1996 Jan; 19(1):8-11. PubMed ID: 8720525
    [Abstract] [Full Text] [Related]

  • 44. Effects of hormone replacement therapy and hepatic lipase polymorphism on serum lipid profiles in postmenopausal Japanese women.
    Somekawa Y, Umeki H, Kobayashi K, Tomura S, Aso T, Hamaguchi H.
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4766-70. PubMed ID: 12364471
    [Abstract] [Full Text] [Related]

  • 45. Comparison of apolipoprotein-B/apolipoprotein-AI in subjects with versus without the metabolic syndrome.
    Sierra-Johnson J, Somers VK, Kuniyoshi FH, Garza CA, Isley WL, Gami AS, Lopez-Jimenez F.
    Am J Cardiol; 2006 Nov 15; 98(10):1369-73. PubMed ID: 17134631
    [Abstract] [Full Text] [Related]

  • 46. Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis.
    de Sain-van der Velden MG, Kaysen GA, Barrett HA, Stellaard F, Gadellaa MM, Voorbij HA, Reijngoud DJ, Rabelink TJ.
    Kidney Int; 1998 Apr 15; 53(4):994-1001. PubMed ID: 9551409
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Hyperhomocysteinaemia is associated with low plasma apolipoprotein AI levels in patients with impaired glucose tolerance.
    Liu J, Wang Y, Fan H, Miao L, Zhang H, Wang G.
    Diab Vasc Dis Res; 2015 Jul 15; 12(4):298-301. PubMed ID: 25920915
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. [Serum lipids and apolipoproteins AI, B100, CI and CII in noninsulin-dependent diabetics].
    Liu BW, Liang JS, Fu MD.
    Zhonghua Nei Ke Za Zhi; 1988 Oct 15; 27(10):627-9, 653-4. PubMed ID: 3147855
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Alterations in apolipoprotein B-48 in the postprandial state in NIDDM.
    Curtin A, Deegan P, Owens D, Collins P, Johnson A, Tomkin GH.
    Diabetologia; 1994 Dec 15; 37(12):1259-64. PubMed ID: 7895956
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Androgen activity as a risk factor for impaired glucose tolerance in postmenopausal women.
    Larsson H, Ahrén B.
    Diabetes Care; 1996 Dec 15; 19(12):1399-403. PubMed ID: 8941471
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. Study of genetic prediabetic south Indian subjects. Importance of hyperinsulinemia and beta-cell dysfunction.
    Snehalatha C, Ramachandran A, Satyavani K, Latha E, Viswanathan V.
    Diabetes Care; 1998 Jan 15; 21(1):76-9. PubMed ID: 9538973
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Comparison of the effects of nilvadipine and captopril on glucose and lipid metabolism in NIDDM patients with hypertension.
    Kawai K, Suzuki S, Murayama Y, Watanabe Y, Yamashita K.
    Diabetes Res Clin Pract; 1992 May 15; 16(2):137-43. PubMed ID: 1600852
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.